SLI
2.052,56
PKT
-0,18
PKT
-0,01
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.05.25 | ams-OSRAM Buy | Deutsche Bank AG | |
| 08.05.25 | Zurich Insurance Sell | UBS AG | |
| 07.05.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.05.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 06.05.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 05.05.25 | UBS Kaufen | DZ BANK | |
| 02.05.25 | ams-OSRAM Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 02.05.25 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 02.05.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 02.05.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | ams-OSRAM Equal Weight | Barclays Capital | |
| 01.05.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | ams-OSRAM Buy | UBS AG | |
| 01.05.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Novartis Buy | Deutsche Bank AG | |
| 30.04.25 | Novartis Kaufen | DZ BANK | |
| 30.04.25 | UBS Outperform | RBC Capital Markets | |
| 30.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 30.04.25 | UBS Hold | Jefferies & Company Inc. | |
| 30.04.25 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novartis Hold | Jefferies & Company Inc. | |
| 29.04.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 29.04.25 | Novartis Neutral | UBS AG | |
| 29.04.25 | Novartis Outperform | Bernstein Research | |
| 28.04.25 | Roche Sell | Deutsche Bank AG | |
| 28.04.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.04.25 | Nestlé Kaufen | DZ BANK | |
| 25.04.25 | Roche Buy | UBS AG | |
| 25.04.25 | Roche Sell | Deutsche Bank AG | |
| 24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.25 | Roche Kaufen | DZ BANK | |
| 24.04.25 | Richemont Outperform | Bernstein Research | |
| 24.04.25 | Nestlé Neutral | UBS AG | |
| 24.04.25 | Nestlé Market-Perform | Bernstein Research | |
| 24.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 24.04.25 | Roche Buy | UBS AG |